Procurement Summary
Country : USA
Summary : Site Visit Notice - NAMRU SOUTH
Deadline : 03 Sep 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 105878785
Document Ref. No. : N0018924RZTBD
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
The Naval Medical Research Unit SOUTH (NAMRU SOUTH) mission is to conduct biomedical research in infectious diseases and global health to meet U.S. Navy requirements and deliver lifesaving products including knowledge, technology, and medical materiel to sustain the effectiveness of the uniformed service members. NAMRU SOUTH conducts research studies to support US military personnel readiness and Force Health Protection (FHP). Moreover, NAMRU SOUTH provides sustainable infectious diseases research support to the host nation Ministry of Health, other government agencies, universities and military through field studies, infectious diseases surveillance and epidemiologic studies, vaccine and drug clinical trials, test/evaluation of technologies and trainingNAMRU SOUTH is hosting site visits for any interested vendor that can meet the work load of an upcoming requirement.The site visit is intended as an engagement session for vendors to see day-to-day operations. NAMRU SOUTH is especially interested in vendors that have extensive experience in the areas of: Collection of data and support regulated studiesManagerial, administrative, direct labor personnel, materials, transportation, and other pertinent services that are necessary to accomplish all work requiredSupport research in the following areas (but not limited to) a) vaccine trials b) drug studies c.) test and evaluation of new technology, d.) epidemiologic studies and biosurveillance of infectious diseases, surveillance of vectors, e.) development / evaluation of devices and therapeutic countermeasures for malaria, bacterial causes of infectious diarrhea, emerging viral pathogens (e.g., dengue, chikungunya, Zika), influenza viruses, leishmaniasis, and multi-drug resistant bacteria.Support in maintaining U.S.Federal Drug Administration (FDA) regulatory standards to conduct clinical studies in accordance with Good Clinical Practices (GCP) and the International Conference on Harmonization (ICH).AGENDA...
Active Contract Opportunity
Notice ID : N0018924RZTBD
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEPT OF THE NAVY
Major Command : NAVSUP
Sub Command : NAVSUP GLOBAL LOGISTICS SUPPORT
Sub Command 2 : NAVSUP FLC NORFOLK
Office: NAVSUP FLT LOG CTR NORFOLK
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 14, 2024 05:58 am EDT
Original Response Date:
Inactive Policy: Manual
Original Inactive Date: Sep 03, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code:
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Place of Performance:
Documents
Tender Notice